GSK3B and breast carcinoma: In line with these findings, Liu et, al. demonstrated TAGLN2 promotes paclitaxel resistance and the migration and invasion of breast cancer by directly interacting with PTEN and activating the PI3K/Akt/GSK-3β pathway68.